Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis

Rademacher Jessica, Schulz Angela, Hedtfeld Silke, Stanke Frauke, Ringshausen Felix, Welte Tobias, Tümmler Burkhard

Source: Eur Respir J 2016; 47: 322-324
Journal Issue: January

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rademacher Jessica, Schulz Angela, Hedtfeld Silke, Stanke Frauke, Ringshausen Felix, Welte Tobias, Tümmler Burkhard. Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis. Eur Respir J 2016; 47: 322-324

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006

Nasal potential difference measurements in patients with atypical cystic fibrosis
Source: Eur Respir J 2001; 17: 1208-1215
Year: 2001



CFTR: cystic fibrosis and beyond
Source: Eur Respir J 2014; 44: 1042-1054
Year: 2014



Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease
Source: Eur Respir J 2009; 34: 772
Year: 2009


Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients
Source: Eur Respir J 2004; 23: 679-684
Year: 2004



Potentiating and correcting mutant CFTR in patients with cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 129-149
Year: 2014


Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
Source: Eur Respir Rev 2013; 22: 58-65
Year: 2013



NTM in cystic fibrosis and non-CF bronchiectasis
Source: ERS Course 2015
Year: 2015

A novel CFTR mutation found in a Chinese cystic fibrosis patient
Source: Eur Respir J 2005; 26: Suppl. 49, 402s
Year: 2005

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
Source: ERJ Open Res, 5 (2) 00082-2019; 10.1183/23120541.00082-2019
Year: 2019



Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017


Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019


Immuno-allertypes in non-cystic fibrosis  bronchiectasis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021